COVID-19 Pandemic and Psoriasis: Effects on Disease Severity, Mental Health, and Treatment Adherence: A Multicenter Cross-Sectional Observational Study
Dermatology and Dermatitis · 25.11.2022 · 07 (03) · 01-15
DOI: 10.31579/2578-8949/213 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Dermatology and Dermatitis, online erschienen am 25.11.2022. Verfasst von Ahmed Adel Ali Ali * und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Psoriasis is a chronic immune-mediated inflammatory disease associated with significant physical, psychological, and social burden. The COVID-19 pandemic and lockdown measures created major challenges for patients with chronic diseases through healthcare disruption, limited medication accessibility, financial difficulties, and increased psychological stress, which may have negatively affected psoriasis severity and patient well-being. Objective: to investigate the impact of the COVID-19 pandemic and lockdown on disease severity, mental health, quality of life, treatment accessibility, coping strategies, and financial burden among patients with psoriasis.
Methods
A multicenter cross-sectional observational study was conducted on 141 psoriasis patients attending the hospitals. Sociodemographic, clinical, psychological, and financial data were collected through patient interviews and medical records. Disease severity was assessed using Psoriasis Area and Severity Index (PASI), Body Surface Area (BSA), and Psoriasis Disability Index (PDI). Psychological assessment included Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Perceived Stress Scale (PSS). Health-related quality of life was evaluated using the SF-36 questionnaire.
Results
The mean age of participants was 41.19 ± 13.68 years, and 55.3% were males. Psoriasis symptoms worsened moderately to severely in 64.5% of patients during lockdown. Significant increases were observed in PASI, BSA, and PDI scores after lockdown (p
Zitieren
APA
*, A. A. A. A., Saber, F., & Mahdy, M. (2022). COVID-19 Pandemic and Psoriasis: Effects on Disease Severity, Mental Health, and Treatment Adherence: A Multicenter Cross-Sectional Observational Study. Dermatology and Dermatitis, 07(03), 01-15. https://doi.org/10.31579/2578-8949/213
Vancouver
* AAAA, Saber F, Mahdy M. COVID-19 Pandemic and Psoriasis: Effects on Disease Severity, Mental Health, and Treatment Adherence: A Multicenter Cross-Sectional Observational Study. Dermatology and Dermatitis. 2022;07(03):01-15. doi:10.31579/2578-8949/213
BibTeX
@article{2022,
author = {*, Ahmed Adel Ali Ali and Saber, Fatema and Mahdy, Marwa},
title = {COVID-19 Pandemic and Psoriasis: Effects on Disease Severity, Mental Health, and Treatment Adherence: A Multicenter Cross-Sectional Observational Study},
journal = {Dermatology and Dermatitis},
year = {2022},
volume = {07},
number = {03},
pages = {01--15},
doi = {10.31579/2578-8949/213}
}
EUVIMED